Clinical Trial Update: A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the ForeCYTE Breast Aspirator for cytological testing of nipple aspirate fluid in women aged 30-55 has been withdrawn. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome

Drugs mentioned

• ForeCYTE Breast Aspirator

Snippet

Sponsor: Atossa Therapeutics, Inc. | Conditions: Breast Cancer, Preneoplastic Conditions, BRCA | Phase 3 | Status: WITHDRAWN